期刊文献+

阿托伐他汀钙对2型糖尿病左室舒张功能不全的短期疗效 被引量:1

The therapeutic effect of atorvastatin on left ventricular diastolic dysfunction in type 2 diabetes mellitus in short term
原文传递
导出
摘要 目的 观察阿托伐他汀钙对2型糖尿病左室舒张功能不全的疗效,为早期防治糖尿病心脏损害提供临床依据.方法 将52例2型糖尿病左室舒张功能不全患者按随机数字表法分为对照组和他汀组,每组各26例,对照组给予常规降糖治疗,他汀组在对照组基础上加用阿托伐他汀钙10 mg/d,共治疗16周,观察两组治疗前后三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(GHbA1c)、高敏C反应蛋白(hs-CRP)水平,并利用脉冲多普勒评价治疗前后舒张早期左室充盈波(E峰)最大流速(VE)、舒张晚期左房收缩波(A峰)最大流速(VA)、VE/VA比值、E峰减速度(DC)等.结果 两组治疗后TG、TC、LDL-C、GHbA1c均较治疗前显著下降(P〈0.05).治疗后他汀组TC、LDL-C、hs-CRP均较对照组显著下降(P〈0.05).他汀组治疗后与治疗前比较,VE、VE/VA比值、DC显著增大(P〈0.05),VA显著降低(P〈0.05);与对照组治疗后比较,VE/VA比值、DC显著增大[1.390 ±1.761比0.897 ±0.089;(680 ±78)cm/s^2比(583±64)cm/s^2,P值均〈0.05].VENA比值与GHbA1c、hs-CRP呈显著负相关(t值分别为-6.232、-2.549,P值分别为0.01、0.03).结论 阿托伐他汀钙能显著改善2型糖尿病左室舒张功能不全.他汀类药物的抗炎作用是其机制之一. Objective To investigate the therapeutic effect and mechanism of atorvastatin on left ventricular diastolic dysfunction(LVDD)in type 2 diabetes mellitus(T2DM).Methods Fifty-two T2DM patients with LVDD were divided randomly into statin group(26 cases)and control group(26 cases).The statin group received atorvastatin(10 mg/d)on the basis of conventional lower blood gluconse treatment of control group,and 16 weeks were observed.The levels of triacylglyceml(TG),total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),glycosyhted hemoglobin 1(GHbA1c),high sensitive C-reactive protein(hs-CRP)were detected.The velocity of E wave(VE),velocity of A wave(VA),VE/VA,deceleration of E wave(DC) was determined before and after treatment by pulse Doppler.Results TG,TC,LDL-C,GHbA1c was significantly decreased after treatment in two groups(P〈0.05).After treatment the levels of TC,LDL-C,hs-CRP in stalin group were significantly lower than those in control group(P〈0.05).After treatment the levels of VE,VF/VA,DC were significantly increased and VA was significantly decreased in statin group(P〈0.05).Compared with that in control group,VE/VA and DC were significantly increased in statin group after treatment[1.390±1.761 vs 0.897±0.089;(680 ±78)cm/s2 vs(583 ±64)cm/s2,P〈0.05].VE/VA level was inversely associated with GHbA1c(t=-6.232,P=0.01)and hs-CRP(t=-2.549,P=0.03).Conclusions Atorvastatin con significandy improve LVDD in T2DM.The anti-inflammatory effect of statins is one of the mechanisms.
作者 胡硕强
出处 《中国医师进修杂志》 2010年第16期15-17,共3页 Chinese Journal of Postgraduates of Medicine
关键词 糖尿病 2型 C反应蛋白质 阿托伐他汀钙 左室舒张功能不全 Diabetes mellitus,type 2 C-reactive protein Atorvastatin Left ventricular diastolic dysfunction
  • 相关文献

参考文献10

  • 1Zile MR,Brutsaert DL.New concepts in diastolic dysfunction and diastolic heart failure:Part Ⅱ:causal mechanisms and treatment.Circulation,2002,105(12):1503-1508.
  • 2Vasan RS,Levy D.Defining diastolic heart failure:a call for standardized diagnostic criteria.Circulation,2000,101(17):2020-2021.
  • 3陈一天,江时森.糖尿病心肌病发病机制及病理生理改变的研究现状[J].医学研究生学报,2003,16(10):795-797. 被引量:9
  • 4Tumer RC.The UK.Prospective diabetes study.A review.Diabetes Care,1998,21 Suppi 3:S35-38.
  • 5Astorri,Fiorina P,Contini GA,et al.Isolated and preclinical impairment of left ventricular filling in insulin-dependent and noninsulin-depandant diabetic patients.Clin Cardial,1997,20(6):536-540.
  • 6Fang ZY,Prins JB,Marwick TH.Diabetic cardiomyopathy:evidence,mechanisms,and therapeutic implications.Endocr Bey,2004,25(4):543-567.
  • 7Fukuta H,Sane DC,Brucks S,et al.Statin therapy may be associated with lower mortality in patients with diastolic heart failure:a preliminary report.Circulation,2005,112(3):357-363.
  • 8Shah R,Wang Y,Foody JM.Effect of statins,angiotensinconverting enzyme inhibitora,and beta blockers on survival in patients 》or=65 years of age with heart failure and preserved left ventricular systolic function.Am J Cardiol,2008,101(2):217-222.
  • 9牛海燕,黄小琴,智光,刘福平,刘敏,丁桂春.超声心动图对2型糖尿病左心室功能的评价[J].解放军医学杂志,2006,31(5):419-421. 被引量:3
  • 10李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:254

二级参考文献40

  • 1Liu JE,Robbins DC,Palmieri V et al.Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes.J Am Coll Cardiol,2003,41:2022.
  • 2Liu J,Masurekar MR,Vatner DE et al.Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.Am J Physiol Heart Circ Physiol,2003,285:2587.
  • 3Vittorio PA,Jonathan N,Donna K et al.Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects:Hypertension Genetic Epidemiology Network(HyperGEN) Study.Circulation,2001,103(1):102.
  • 4Schmidt MI, Duncan BB, Scharrct AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 1999,353:1649-1652.
  • 5Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 2001,50:2384-2389.
  • 6Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
  • 7Festa A, Ralph BD, Russell PT, et al. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 (PAI-1) predict the development of type 2 diabetes mellitus: the insulin resistance atherosclerosis study (IRAS). Diabetes, 2000,49(Suppl 1):A24-A25.
  • 8Duncan BB, Schmidt MI, Offenbacher S, et al. Factor Ⅷ and other hemostasis variables are related to incident diabetes in adults. Diabetes care, 1999,22:767-772.
  • 9Lindsay RS, Krakoff J, Hanson RL, et al. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes, 2001,50:1598-1603.
  • 10Mcneely MJ, Bokyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care, 1999,22:65-70.

共引文献263

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部